Echelard Yann's Form 4 filing
TG Therapeutics, Inc. (TGTX) · filed Jun 16, 2025
- Accession no.
- 0001437749-25-020546
- Filed
- Jun 16, 2025
- Trade date
- Jun 12-13, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $369.4K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Echelard YannCIK 0001561958 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2025 | Common Stock | AGrant or awardAcquired | +14,718 | $0.00 | $0 | 238,816 | Direct | |
| Jun 13, 2025 | Common Stock | SSaleDisposed | −10,000 | $36.94 | −$369,400 | 228,816 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.